Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus (Q24240609)

2

0 references

Matthew Page

3

0 references

Denise O'Connor

4

0 references

Jonathan Shaw

Cochrane Database of Systematic Reviews

5

0 references

publication date

20 January 2010

0 references

published in

0 references

cites work

In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Continuous subcutaneous insulin infusion versus multiple daily injections in adolescents with type I diabetes mellitus: a randomized open crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabet

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Effects of insulin pump vs. injection treatment on quality of life and impact of disease in children with type 1 diabetes mellitus in a randomized, prospective comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

The response of diabetic retinopathy to 41 months of multiple insulin injections, insulin pumps, and conventional insulin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

A 2-year pilot trial of continuous subcutaneous insulin infusion versus intensive insulin therapy in patients with newly diagnosed type 1 diabetes (IMDIAB 8).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Comparison of continuous subcutaneous insulin infusion with multiple insulin injections using the NovoPen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Improved treatment satisfaction but no difference in metabolic control when using continuous subcutaneous insulin infusion vs. multiple daily injections in children at onset of type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Intensive insulin therapy with insulin lispro: a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Long-term, ambulatory, subcutaneous insulin infusion versus multiple daily injections in brittle diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

The WHO (Ten) Well-Being Index: validation in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Improved in vivo insulin effect during continuous subcutaneous insulin infusion in patients with IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Effect of insulin pump treatment for one year on renal function and retinal morphology in patients with IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Effect of plasma glucose control by continuous subcutaneous insulin infusion on nerve conduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Hydroperoxides in plasma are reduced by intensified insulin treatment. A randomized controlled study of IDDM patients with microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Observations on C-peptide and free insulin in the blood during continuous subcutaneous insulin infusion and conventional insulin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Patient perception and use of an insulin injector/glucose monitor combined device.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Comparison of Plasma Glucose and Plasma Free Insulin During CSII and Intensified Conventional Insulin Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

The treatment of unstable type I diabetes: Conventional versus portable pump insulin administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

The effect of six months continuous subcutaneous insulin infusion on kidney function and size in insulin-dependent diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Effect of continuous subcutaneous insulin infusion on kidney function and size in IDDM patients: a 2 year controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Near normoglycemia for 1 year has no effect on platelet reactivity, factor VIII, and von Willebrand factor in insulin-dependent diabetes mellitus: a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Continuous subcutaneous insulin infusion in diabetes mellitus. A year's prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

A randomized, controlled study of insulin pump therapy in diabetic preschoolers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Sustained normoglycemia and remission phase in newly diagnosed type I diabetic subjects. Comparison between continuous subcutaneous insulin infusion and conventional therapy during a one year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Glycemic parameters with multiple daily injections using insulin glargine versus insulin pump

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Clinical application of insulin pumps in the management of insulin dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Blood glucose control on Sunday in IDDM patients: intensified conventional insulin therapy versus continuous subcutaneous insulin infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Continuous subcutaneous insulin infusion (CSII), multiple injections (MI) and conventional insulin therapy (CT) in self-selecting insulin-dependent diabetic patients. A comparison of metabolic control, acute complications and patient preferences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Low-dose continuous insulin therapy for diabetic ketoacidosis. Prospective comparison with "conventional" insulin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

A quality-of-life assessment of intensive insulin therapy using insulin lispro switched from short-acting insulin and measured by an ITR-QOL questionnaire: a prospective comparison of multiple daily insulin injections and continuous subcutaneous ins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Plasma immunoreactive somatostatin response to arginine after glycemic control with continuous subcutaneous insulin infusion in type I diabetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Postprandial blood glucose response to exercise in type I diabetes: comparison between pump and injection therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Altered recognition of hypoglycaemic symptoms in type I diabetes during intensified control with continuous subcutaneous insulin infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Observations on blood lipid and intermediary metabolite concentrations during conventional insulin treatment or CSII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Effect of octreotide on blood glucose and counterregulatory hormones in insulin-dependent diabetic patients: the role of dose and route of administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Continuous subcutaneous insulin infusion versus injection therapy: a randomized cross-over trial under usual diabetic clinic conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Clinical use of the insulin infusion pump in 100 patients with type I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Hypoglycemia and counterregulation in insulin-dependent diabetic patients: a comparison of continuous subcutaneous insulin infusion and conventional insulin injection therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Glucose disposal and intermediary metabolism during one year of continuous subcutaneous insulin infusion (CSII)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Diabetic retinopathy after 3 years' treatment with continuous subcutaneous insulin infusion (CSII).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Continuous subcutaneous insulin Infusion: Good blood glucose control for up to 4 days

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Continuous subcutaneous insulin infusion: improved blood-glucose and intermediary-metabolite control in diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Glycemic control in insulin-dependent diabetes mellitus. Comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Continuous subcutaneous insulin infusion in adults: glycemic advantage is predicted by venous plasma C-peptide concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Improved metabolic control in diabetic adolescents using the continuous glucose monitoring system (CGMS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Multiple daily self-glucose monitoring: its essential role in long-term glucose control in insulin-dependent diabetic patients treated with pump and multiple subcutaneous injections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Comparison between continuous subcutaneous insulin infusion and multiple injections of insulin. A one-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Metabolic Response to Fasting Exercise in Adolescent Insulin-Dependent Diabetic Subjects Treated with Continuous Subcutaneous Insulin Infusion and Intensive Conventional Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Predicting nocturnal hypoglycemia in patients with type I diabetes treated with continuous subcutaneous insulin infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

The cost-effectiveness of continuous subcutaneous insulin infusion compared with multiple daily injections for the management of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Meta-analysis of short-acting insulin analogues in adult patients with type 1 diabetes: continuous subcutaneous insulin infusion versus injection therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Improved insulin sensitivity in patients with type I diabetes mellitus after CSII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Plasma somatostatin and plasma glucagon in long-term IDDM without residual B-cell function. No effect of different long-term metabolic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Continuous Subcutaneous Insulin Infusion in Children and Adolescents with Diabetes Mellitus: Decreased HbA1c with Low Risk of Hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Restoration of normal lipid and aminoacid metabolism in diabetic patients treated with a portable insulin-infusion pump

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

The use of insulin pumps improves the metabolic control in children and adolescents with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Continuous Subcutaneous Insulin Infusion Therapy Decreases Insulin Resistance in Type 1 Diabetes*

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

The accelerating epidemic of childhood diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Effects of insulin in relatives of patients with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Intervening before the onset of Type 1 diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

Effect of insulin infusion pump use on diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Diabetic retinopathy after two years of intensified insulin treatment. Follow-up of the Kroc Collaborative Study. The Kroc Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Effects of different insulin administration modalities on vitamin D metabolism of insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Implanted constant basal rate insulin infusion devices for Type 1 (insulin-dependent) diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Improvement of diabetic control by continuous subcutaneous insulin infusion therapy changes fatty acid composition of serum lipids and erythrocytes in type 1 (insulin-dependent) diabetes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Effects of one year of near-normoglycemia on peripheral nerve function in type 1 (insulin-dependent) diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Comparison between multi-injection and continuous subcutaneous insulin therapy in insulin-dependent diabetic inpatients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Short-term subcutaneous insulin infusion in diabetic children. Comparison with three daily insulin injections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

A new approach to improved metabolic control in diabetics: continuous subcutaneous insulin infusion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Effects of intensified insulin treatment on various lesions of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

High density lipoprotein subfractions during continuous insulin infusion therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

A self-controlled study of the effect of continuous subcutaneous insulin infusion on diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Comparison of the effects of continuous subcutaneous infusion and split-mixed injection of insulin on nerve function in type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Glucagon responses to intravenous arginine and oral glucose in insulin-dependent diabetic patients during six months conventional or continuous subcutaneous insulin infusion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Effects of continuous insulin infusion therapy on lipoprotein surface and core lipid composition in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Comparison of platelet thromboxane synthesis in diabetic patients on conventional insulin therapy and continuous insulin infusions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Feasibility of strict diabetes control in insulin-dependent diabetic adolescents

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Oscillatory potentials, macular recovery time, and diabetic retinopathy through 3 years of intensified insulin treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Metabolic control in newly kidney transplanted insulin-dependent diabetics: improvement by insulin pump treatment (CSII)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Metabolic Effects of Intensified Insulin Therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Long-term Improvement in Metabolic Control of Unstable Type I Diabetes by s.c. Insulin Injection Patterns Based on the Dose Profiles Required by Bed-Side Artificial Beta-Cell1)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Effect of different insulin administration modalities on vitamin D metabolism of insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Platelet aggregation in type 1 diabetes without microvascular disease during continuous subcutaneous insulin infusion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Kidney function during 12 months of strict metabolic control in insulin-dependent diabetic patients with incipient nephropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Evaluation of the psychosocial impact of the MiniMed variable-rate implantable insulin pump

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

A controlled study of the influence of continuous subcutaneous insulin infusion treatment on diabetic retinopathy during pregnancy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

A crossover comparison of continuous insulin infusion and conventional injection treatment of type I diabetes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Antithrombin III activity, von Willebrand factor antigen and platelet function in young diabetic patients treated with multiple insulin injections versus insulin pump treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Serum levels of insulin-like growth factor (IGF) I, II and IGF binding protein in diabetic adolescents treated with continuous subcutaneous insulin infusion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Continuous subcutaneous insulin injection for self-care of young patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Hypoglycemic episodes during continuous subcutaneous insulin infusion: decreased frequency but increased susceptibility

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Urinary insulin excretion rate: an index of free insulinaemia in insulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Patterns of hyperinsulinaemia in type 1 diabetic patients with and without nephropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Continuous subcutaneous insulin infusion (CSII) versus conventional injection therapy in newly diagnosed diabetic children: two-year follow-up of a randomized, prospective trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Diabetic retinopathy after one year of improved metabolic control obtained by continuous subcutaneous insulin infusion (CSII)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Reversal of insulin resistance in type I diabetes after treatment with continuous subcutaneous insulin infusion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Metabolic control in newly diagnosed type 1 diabetic children. Effect of continuous subcutaneous infusion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Preconceptional diabetes control in insulin-dependent diabetes mellitus patients with continuous subcutaneous insulin infusion therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Metabolic effects of physical exercise in insulin-dependent diabetics controlled by continuous subcutaneous insulin infusion or conventional injection therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

The influence of strict control on diabetic complications

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Preconceptional treatment with insulin infusion pumps in insulin-dependent diabetic women with particular reference to prevention of congenital malformations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Diurnal plasma profiles of metabolite and hormone concentration in insulin-dependent diabetic patients during conventional insulin treatment and continuous subcutaneous insulin infusion. A controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Continuous insulin infusion therapy and retinopathy in patients with type I diabetes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. The Oslo Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Intermediary metabolism, insulin sensitivity and insulin receptor status under comparable long-term therapy with insulin injections and continuous subcutaneous insulin infusion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

The improved response in endogenous insulin due to continuous subcutaneous infusion of insulin therapy in juvenile diabetes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

The effect of improved diabetic control on plasma lipid and lipoprotein levels: a comparison of conventional therapy and continuous subcutaneous insulin infusion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Correction of exercise-induced microalbuminuria in insulin-dependent diabetics after 3 weeks of subcutaneous insulin infusion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

The effect of continuous subcutaneous insulin infusion on very-low-density lipoprotein triglyceride metabolism in type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Conference on insulin pump therapy in diabetes. Multicenter study of effect on microvascular disease. The pump life. Patient responses and clinical and technological problems

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Comparison of stereofundus photographs in patients with insulin-dependent diabetes during conventional insulin treatment or continuous subcutaneous insulin infusion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Clinical predictors of retinopathy and its progression in patients with type I diabetes during CSII or conventional insulin treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Increase in insulin antibodies during continuous subcutaneous insulin infusion and multiple-injection therapy in contrast to conventional treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Autonomic and somatosensory nerve function after 2 years of continuous subcutaneous insulin infusion in type I diabetes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Counterregulatory hormone responses preserved after long-term intravenous insulin infusion compared to continuous subcutaneous insulin infusion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Effects of continuous subcutaneous insulin infusion versus multiple injections on insulin receptors in insulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Continuous subcutaneous insulin infusion treatment in insulin-dependent diabetic patients: a comparison with conventional optimized treatment in a long-term study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: improved control with CSII

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Overnight metabolic control with pulsed intermittent versus continuous subcutaneous insulin infusion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Intensified Insulin Therapy in the Type I Diabetic Adolescent: A Controlled Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Continuous subcutaneous insulin infusion (Mill-Hill Infuser) versus multiple injections (Medi-Jector) in the treatment of insulin-dependent diabetes mellitus and the effect of metabolic control on microangiopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Incidence of hypoglycemic episodes in diabetic patients under continuous subcutaneous insulin infusion and intensified conventional insulin treatment: assessment by means of semiambulatory 24-hour continuous blood glucose monitoring

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Accommodating planned exercise in type I diabetic patients on intensive treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Continuous subcutaneous insulin infusion does not provoke significant acute-phase response

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Lipoprotein changes during continuous subcutaneous insulin infusion in insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Exercise capacity and cardiac function in type 1 diabetic patients treated with continuous subcutaneous insulin infusion. A controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Early morning glycaemia and the metabolic consequences of delaying breakfast/morning insulin. A comparison of continuous subcutaneous insulin infusion and multiple injection therapy with human isophane or human ultralente insulin at bedtime in insul

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Children with type 1 diabetes: where are we at?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

Intensive conventional and insulin pump therapies in adult type I diabetes. A crossover study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005103.PUB2

7 January 2021

10.1002/14651858.CD005103.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

20091571

1 reference

Consolidated OpenCitations Corpus – April 2017